Skip to main content

Boughton Soleil's Form 4 filing

Hims & Hers Health, Inc. (HIMS) · filed Oct 18, 2022

Accession no.
0001773751-22-000219
Filed
Oct 18, 2022
Trade date
Oct 14-18, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market sales total $156.7K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Boughton SoleilCIK 0001837817Officer (Chief Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 14, 2022Class A Common StockSSaleDisposed−22,003$5.04F2−$110,895.12340,601Direct
Oct 17, 2022Class A Common StockSSaleDisposed−4,785$4.43−$21,197.55335,816Direct
Oct 18, 2022Class A Common StockSSaleDisposed−5,545$4.44−$24,619.8330,271Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Price reported constitutes the average weighted price of shares purchased. Shares were purchased at varying prices in the range of $4.76- $5.04. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)